Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren's syndrome.

Literature DB >> 29936436

Short-term and low-dose IL-2 therapy restores the Th17/Treg balance in the peripheral blood of patients with primary Sjögren's syndrome.

Miao Miao¹, Zhenye Hao¹, Yingying Guo¹, Xiaoying Zhang², Shengxiao Zhang¹, Jing Luo², Xiangcong Zhao², Chen Zhang², Xiaoqing Liu¹, Xiaoyan Wu², Dan Xu¹, Jinfang Zhao³, Xuechun Lu⁴, Chong Gao⁵, Xiaofeng Li².

Abstract

Entities: Disease Gene Species

Keywords: Interleukin; Th17 cell; primary sjögren’s syndrome; treg cell

Mesh：

Substances：

Year: 2018 PMID： 29936436 DOI： 10.1136/annrheumdis-2018-213036

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

Keyword Cloud
Cited

× No keyword cloud information.

28 in total

Review 1. Biologic therapy in Sjögren's syndrome.

Authors: Qin Shao
Journal: Clin Rheumatol Date: 2020-10-27 Impact factor: 2.980

2. Altered levels of circulating CD8⁺CXCR5⁺PD-1⁺T follicular cytotoxic cells in primary Sjögren's syndrome.

Authors: Xuwen Zhai; Yanlin Wang; Hui Guo; Zhaojun Liang; Min Feng; Yanyao Wu; Yan Qin; Xiangcong Zhao; Chong Gao; Jing Luo
Journal: Clin Rheumatol Date: 2022-02-16 Impact factor: 2.980

3. A Decreased Absolute Number of T_reg Cells in Patients with Active Rheumatoid Arthritis is Associated with Elevated Serum Osteopontin Levels with Disease Progression.

Authors: Jian-Fang Xie; Jia Wang; Huan-Huan Bai; Jiao-Jiao He; Rui-Huan Jia; Xia Wang; Wen-Qi Zhang; Xiang-Cong Zhao; Xian-Cheng Zhang; Guang-Ying Liu; Xiao-Feng Li
Journal: Adv Ther Date: 2022-05-23 Impact factor: 4.070

4. PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice.

Authors: Xingyi Guo; Weiyu Dang; Na Li; Ying Wang; Deming Sun; Hong Nian; Ruihua Wei
Journal: Invest Ophthalmol Vis Sci Date: 2022-06-01 Impact factor: 4.925

Review 5. Immune regulation of the ocular surface.

Authors: Yihe Chen; Shudan Wang; Hamid Alemi; Thomas Dohlman; Reza Dana
Journal: Exp Eye Res Date: 2022-03-04 Impact factor: 3.770

Review 6. Immunobiology of T Cells in Sjögren's Syndrome.

Authors: Yuan Yao; Jin-Fen Ma; Christopher Chang; Ting Xu; Cai-Yue Gao; M Eric Gershwin; Zhe-Xiong Lian
Journal: Clin Rev Allergy Immunol Date: 2021-02 Impact factor: 8.667

Review 7. Interleukin-2 and regulatory T cells in rheumatic diseases.

Authors: Antonios G A Kolios; George C Tsokos; David Klatzmann
Journal: Nat Rev Rheumatol Date: 2021-11-02 Impact factor: 20.543

8. Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis.

Authors: Sheng-Xiao Zhang; Jia Wang; Cai-Hong Wang; Rui-Huan Jia; Ming Yan; Fang-Yuan Hu; Guang-Ying Liu; Xue-Yu Liu; Jing Luo; Chong Gao; Xiao-Feng Li
Journal: Ther Adv Musculoskelet Dis Date: 2021-04-28 Impact factor: 5.346

9. Mesenchymal stem cells inhibited the differentiation of MDSCs via COX2/PGE2 in experimental sialadenitis.

Authors: Jingjing Qi; Xiaojun Tang; Wenchao Li; Weiwei Chen; Genhong Yao; Lingyun Sun
Journal: Stem Cell Res Ther Date: 2020-07-29 Impact factor: 6.832

10. The numbers of peripheral regulatory T cells are reduced in patients with psoriatic arthritis and are restored by low-dose interleukin-2.

Authors: Jia Wang; Sheng-Xiao Zhang; Yu-Fei Hao; Meng-Ting Qiu; Jing Luo; Yu-Yao Li; Chong Gao; Xiao-Feng Li
Journal: Ther Adv Chronic Dis Date: 2020-04-27 Impact factor: 5.091